| scholarly article | Q13442814 |
| P50 | author | Pratima Chowdary | Q44211043 |
| P2093 | author name string | Peter W Collins | |
| Anton G Saayman | |||
| Ulrike Paulus | |||
| George P Findlay | |||
| P2860 | cites work | The pathophysiology of variant Creutzfeldt-Jacob disease: the hypotheses behind concerns for blood components and products | Q35161215 |
| Correction of abnormal coagulation in chronic liver disease by combined use of fresh-frozen plasma and prothrombin complex concentrates | Q39396897 | ||
| The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study | Q43589291 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | laboratory | Q483242 |
| fresh frozen plasma | Q1225698 | ||
| P304 | page(s) | 69-73 | |
| P577 | publication date | 2004-04-01 | |
| P1433 | published in | British Journal of Haematology | Q4970200 |
| P1476 | title | Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients | |
| P478 | volume | 125 |
| Q37141692 | A multicenter study of plasma use in the United States |
| Q35559573 | A national study of plasma use in critical care: clinical indications, dose and effect on prothrombin time |
| Q45877402 | A practical guideline for the haematological management of major haemorrhage |
| Q35972184 | Adverse effects of plasma transfusion |
| Q60935823 | Association between viscoelastic tests-guided therapy with synthetic factor concentrates and allogenic blood transfusion in liver transplantation: a before-after study |
| Q37195366 | Bleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: a pilot study |
| Q34548386 | Blood transfusion and the anaesthetist: management of massive haemorrhage |
| Q35908250 | Clinical effectiveness of fresh frozen plasma compared with fibrinogen concentrate: a systematic review |
| Q35567088 | Clinical review: Prothrombin complex concentrates--evaluation of safety and thrombogenicity |
| Q35621790 | Clotting factor deficiency in early trauma-associated coagulopathy |
| Q37841228 | Coagulation management in multiple trauma: a systematic review. |
| Q43264764 | Coagulation management in the treatment of multiple trauma |
| Q33380635 | Coagulation management of severe surgical bleeding |
| Q55142869 | Comment on: Early recovery pathway for hepatectomy: data-driven liver resection care and recovery. |
| Q85212338 | Comparative stability of canine and feline hemostatic proteins in freeze‐thaw‐cycled fresh frozen plasma |
| Q45856616 | Cryoprecipitate: no longer the best therapeutic choice in congenital fibrinogen disorders? |
| Q40415916 | Current treatment options for intracerebral hemorrhage |
| Q31049629 | Disseminated Intravascular Coagulation in Secondary Glioblastoma due to Excessive Intraoperative Bleeding: Case Report and Review of the Literature |
| Q26853422 | Early and individualized goal-directed therapy for trauma-induced coagulopathy |
| Q51736921 | Effect of plasma component transfusion on conventional coagulation screening tests. |
| Q30595449 | Effect of thromboelastography (TEG®) and rotational thromboelastometry (ROTEM®) on diagnosis of coagulopathy, transfusion guidance and mortality in trauma: descriptive systematic review |
| Q37188102 | Emergencies associated with pregnancy and delivery: peripartum hemorrhage |
| Q37996341 | Emerging treatment strategies for trauma-induced coagulopathy |
| Q39132227 | Evaluation of a multi-center randomised clinical trial on prophylactic transfusion of fresh frozen plasma: implications for future trials |
| Q38004280 | Evidence for a rationale use of frozen plasma for the treatment and prevention of bleeding |
| Q33733852 | Fibrinogen Early In Severe Trauma studY (FEISTY): study protocol for a randomised controlled trial |
| Q43416132 | Fibrinogen and FXIII dose response effects on albumin-induced coagulopathy |
| Q38151867 | Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy |
| Q85193685 | Fibrinogen concentrate for management of bleeding |
| Q38680285 | Fibrinogen: A Clinical Update on Liver Transplantation |
| Q49130572 | Fresh frozen plasma transfusion fails to influence the hemostatic balance in critically ill patients with a coagulopathy |
| Q33919203 | Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate |
| Q38682353 | Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage: A Statement for Healthcare Professionals from the Neurocritical Care Society and Society of Critical Care Medicine. |
| Q27024386 | Haemostatic management of cardiac surgical haemorrhage |
| Q58085543 | Higher intraoperative plasma transfusion volumes are associated with inferior perioperative outcomes |
| Q37059222 | Impact of experimental haemodilution on platelet function, thrombin generation and clot firmness: effects of different coagulation factor concentrates |
| Q50543031 | Impact of national transfusion indicators on appropriate blood usage in critically ill patients. |
| Q89943293 | Impaired platelet-dependent thrombin generation associated with thrombocytopenia is improved by prothrombin complex concentrates in vitro |
| Q37186526 | Importance of fibrinogen in dilutional coagulopathy after neurosurgical procedures: A descriptive study |
| Q34416339 | Indications and organisational methods for autologous blood transfusion procedures in Italy: results of a national survey |
| Q92260983 | Influence of factor XII deficiency on activated partial thromboplastin time (aPTT) in critically ill patients |
| Q89650502 | Intraoperative Plasma Transfusion Volumes and Outcomes in Cardiac Surgery |
| Q34675297 | Intraoperative transfusion practices in Europe |
| Q26748355 | Is solvent/detergent plasma better than standard fresh-frozen plasma? A systematic review and an expert consensus document |
| Q38631132 | Is there a role for antifibrinolytics in pelvic and acetabular fracture surgery? |
| Q37663835 | Lessons from the aprotinin saga: current perspective on antifibrinolytic therapy in cardiac surgery |
| Q40735865 | Management of coagulopathy associated with postpartum hemorrhage: guidance from the SSC of the ISTH. |
| Q38273794 | Management of traumatic haemorrhage--the European perspective |
| Q33394177 | Percutaneous interventions in the coagulopathic patient |
| Q39227116 | Perioperative Coagulation Management of a Hemophilia A Patient During Cardiac Surgery. |
| Q35106675 | Plasma is ineffective in correcting mildly elevated PT-INR in critically ill children: a retrospective observational study |
| Q38009414 | Plasma transfusion for bedside, radiologically guided, and operating room invasive procedures |
| Q38096457 | Practical coagulation for the blood banker |
| Q38273787 | Practical management of major blood loss |
| Q56674877 | Prevention and Management of Postpartum Haemorrhage |
| Q36066343 | Prophylactic Fresh Frozen Plasma Infusion is Ineffective in Reversing Warfarin Anticoagulation and Preventing Delayed Intracranial Hemorrhage After Falls |
| Q47330575 | Prophylactic Preprocedure Platelet Transfusion Is Associated With Increased Risk of Thrombosis and Mortality |
| Q37897816 | Prothrombin complex concentrate for critical bleeding |
| Q43180952 | Prothrombin complex concentrate vs fresh frozen plasma for reversal of dilutional coagulopathy in a porcine trauma model |
| Q42736164 | Rationalizing the clinical use of frozen plasma |
| Q34988663 | Recommendations for the transfusion management of patients in the peri-operative period. II. The intra-operative period |
| Q37209117 | Recommendations for the transfusion of plasma and platelets |
| Q42096335 | Recommendations for the use of antithrombin concentrates and prothrombin complex concentrates |
| Q33793633 | Recovery of fibrinogen after administration of fibrinogen concentrate to patients with severe bleeding after cardiopulmonary bypass surgery |
| Q37800127 | Reduction in plasma transfusion after enforcement of transfusion guidelines (CME) |
| Q35998384 | Reduction of Fresh Frozen Plasma Requirements by Perioperative Point-of-Care Coagulation Management with Early Calculated Goal-Directed Therapy. |
| Q40153017 | Relative effects of plasma, fibrinogen concentrate, and factor XIII on ROTEM coagulation profiles in an in vitro model of massive transfusion in trauma |
| Q48503140 | Retrospective Review of a Prothrombin Complex Concentrate (Beriplex P/N) for the Management of Perioperative Bleeding Unrelated to Oral Anticoagulation. |
| Q44316500 | Risk factors and impact of major bleeding in critically ill patients receiving heparin thromboprophylaxis |
| Q26863536 | Role of prothrombin complex concentrate in perioperative coagulation therapy |
| Q36923936 | SDH with Bleeding Diathesis-a Management Protocol |
| Q38213153 | Solvent/detergent plasma: pharmaceutical characteristics and clinical experience |
| Q34654443 | Spanish Consensus Statement on alternatives to allogeneic blood transfusion: the 2013 update of the "Seville Document". |
| Q38180819 | State of the art - how I manage coagulopathy in cardiac surgery patients |
| Q37965826 | Systematic review of the efficacy and safety of fibrinogen concentrate substitution in adults |
| Q27339343 | The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition |
| Q37851496 | The coagulopathy of cardiopulmonary bypass. |
| Q35558167 | The conundrum of persistent inappropriate use of frozen plasma |
| Q45866452 | The effect of fresh frozen plasma in critically ill patients. |
| Q34316974 | The how's and why's of evidence based plasma therapy |
| Q37873969 | The practical management of intracerebral hemorrhage associated with oral anticoagulant therapy. |
| Q44465798 | The use of fresh-frozen plasma in England: high levels of inappropriate use in adults and children |
| Q48131336 | The volume-expanding effects of autologous liquid stored plasma following hemorrhage. |
| Q47905915 | Thromboelastometry as a supplementary tool for evaluation of hemostasis in severe sepsis and septic shock |
| Q36086090 | Thromboelastometry-guided hemostatic therapy: an efficacious approach to manage bleeding risk in acute fatty liver of pregnancy: a case report |
| Q61783768 | Tissue factor activated thromboelastography correlates to clinical signs of bleeding in dogs |
| Q46329386 | Transfusion and postpartum haemorrhage |
| Q35559379 | Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy. |
| Q54967793 | Transfusion of Fresh Frozen Plasma in Critically Ill Patients: Effective or Useless? |
| Q35772078 | Transfusion of fresh frozen plasma in non-bleeding ICU patients--TOPIC trial: study protocol for a randomized controlled trial |
| Q33415825 | Transfusion of fresh-frozen plasma in critically ill patients with a coagulopathy before invasive procedures: a randomized clinical trial (CME). |
| Q36230698 | Transfusion practice in massively bleeding patients: time for a change? |
| Q94586344 | Trauma induced clotting factor depletion in severely injured children: a single center observational study |
| Q35248569 | Trauma-induced coagulopathy: impact of the early coagulation support protocol on blood product consumption, mortality and costs. |
| Q85012740 | Treatment of massive bleeding with prothrombin complex concentrate: argument for |
| Q36874231 | Tuscan study on the appropriateness of fresh-frozen plasma transfusion (TuSAPlaT). |
| Q39532850 | Updates on coagulation management in cardiac surgery |
| Q37063465 | Warfarin reversal in anticoagulant-associated intracerebral hemorrhage |
| Q79637584 | [Blood transfusion and adjunctive therapy in the bleeding trauma patient] |
| Q50597212 | [Coagulation management in multiple trauma]. |
| Q82434159 | [Current coagulation diagnostics in intensive care medicine] |
| Q83835017 | [Fresh plasma and concentrates of clotting factors for therapy of perioperative coagulopathy: what is known?] |
| Q81365891 | [Hemorrhaging during pregnancy] |
| Q80852425 | [Management of coagulation after multiple trauma] |
| Q80688834 | [Management of hemostasis disorders after extracorporeal circulation. A clinical therapy algorithm] |
| Q79295125 | [Perioperative coagulation management controlled by thrombelastography. Clinical implementation illustrated by reference to a case of acquired coagulopathy following aortic stab injury] |
| Q79538402 | [Perioperative hemostasis management] |
| Q88311054 | [Use of thrombelastography to guide posttraumatic hemostatic therapy: More coagulation factor concentrates and less allogenic blood transfusion?] |
Search more.